Despite Overly Negative Street Expectations, JPMorgan Stays Positive On Wright Medical


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Over the last twelve months, Wright Medical Group Inc

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

(NASDAQ: WMGI) has evolved into the only orthopedics company publicly traded on U.S. markets.

JPMorgan's Take

JPMorgan's Andrew Hanover upgraded Wright Medical from Neutral to Overweight, increasing the December 2017 price target from $21.00 to $26.00.

The analyst was impressed with Wright's "strong underlying fundamentals" displayed by the company's revenue beat for 1Q16 in May. Although Wright Medical reported Q1 EPS from continuing operations at $(0.38) vs. estimates of $(0.25), the company's revenues beat estimates, reporting $181 million vs. estimates of $171 million.

Overly Negative Street Expectations


FREE REPORT: How To Learn Options Trading Fast

In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, ​a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.


The JPMorgan analyst believes Street expectations were "overly negative [...] for [the] metal-on-metal settlement." "With the CONSERVE metal-on-metal litigation being the primary hurdle weighing on shares, we see ~27 percent upside to current levels (3.3x 2017 EV/Sales)," stated Hanover.

'Recent Product Launches And Gaining Traction'

Hanover believes recent product innovations that have been gaining traction are also positive signs for the company. The analyst was most impressed by products such as "Augment," "Simplicity" and "Salvation."

Tornier Merger

Finally, due to the Tornier merger, Hanover thinks Wright Medical has "leading franchises in both the upper and lower extremities markets, two of the fastest growing segments of the ortho industry, as well as a third leg of growth with Augment." The deal is expected to close by the end of the third quarter or beginning of Q4 according to the analyst.

At time of writing, Wright Medical Group was up 3.31 percent in Wednesday's pre-market session at $21.20.

Did you like this article? Could it have been improved? Please email feedback@benzinga.com to let us know!

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: Analyst ColorBiotechLong IdeasNewsUpgradesHealth CarePrice TargetAnalyst RatingsMoversTrading IdeasGeneralAndrew HanoverJPMorgantornier